Publications

Guselkumab Decreases Key Cellular Inflammatory Processes Across Ileum and Colon Tissue in Crohn’s Disease

Publié en January 2024 AMERICAN JOURNAL OF GASTROENTEROLOGY
January 2024

Guselkumab and Golimumab Combination Induction Therapy in Ulcerative Colitis Results in Early Local Tissue Healing That Is Sustained Through Guselkumab Maintenance Therapy

AMERICAN JOURNAL OF GASTROENTEROLOGY
Previous publication
January 2024

Histologic and Combined Histologic and Endoscopic Outcomes After Guselkumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Week 44 Results From the Phase 3 QUASAR Maintenance Study

AMERICAN JOURNAL OF GASTROENTEROLOGY
Next publication

Authors